Oral administration of inflammatory microenvironment-responsive carrier-free infliximab nanocomplex for the targeted treatment of inflammatory bowel disease
- Resource Type
- Article
- Source
- In
Chemical Engineering Journal 1 October 2022 445 - Subject
- Language
- ISSN
- 1385-8947